中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

MPM Medical CoMatryx Surgical Bovine Collagen Study

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态尚未招聘
赞助商
MPM Medical
合作者
Texas Health Resources

关键词

抽象

The objective of this prospective enrollment study is to collect data confirming safety, performance and clinical benefits of the CoMatryx Surgical Collagen powder at a minimum 1-year follow-up and compare it to a historical control group who did not receive the product at the time of surgery.
The primary objective is to confirm safety and clinical benefits of the product. This will be assessed by recording the rate of wound healing and incidence and frequency of wound care related complications. Relationship of complications to the product should be specified.

描述

The CoMatryx Surgical Collagen powder is a soft tissue repair product made of 100% Type I Bovine collagen. It is non-hydrolyzed and not cross-linked chemically. It is biocompatible, biodegradable and free of synthetics. The product does not have any specific storage requirements.

The CoMatryx Surgical Collagen powder provides a physiologically favorable environment to promote healing at the wound site. When administered, the powder conforms to the wound site and forms a gelatinous occlusive barrier. Along with providing 19 amino acids directly to the wound site it also occludes live nerve endings reducing pain. Treating the wound with the CoMatryx Surgical Collagen powder provides the non-hydrolyzed collagen wound surface promoting autolytic debridement. The powder is effective in all phases of wound healing and can be delivered with antibiotics in areas where there may be a cavity. This product has FDA 510(k) clearance for surgical wounds, full thickness wounds, traumatic wounds and skin tears.

日期

最后验证: 04/30/2020
首次提交: 05/19/2020
提交的预估入学人数: 05/26/2020
首次发布: 05/28/2020
上次提交的更新: 05/28/2020
最近更新发布: 06/01/2020
实际学习开始日期: 05/31/2020
预计主要完成日期: 05/31/2022
预计完成日期: 05/31/2022

状况或疾病

Surgical Wound, Healed

干预/治疗

Device: CoMatryx Surgical Bovine Collagen

-

手臂组

干预/治疗
Intervention Cohort
The CoMatryx surgical collagen powder is a soft tissue repair product made of 100% type I bovine collagen
Historical Cohort
Primary and Revision total hip arthroplasty patients between 18-85 years of age

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
取样方式Non-Probability Sample
接受健康志愿者
标准

Inclusion Criteria:

- • Subjects must be 18 years of age or older

- Subject must be willing and able to sign IRB approved informed consent

- Subject must have a BMI of 35 or higher

- Surgical approach of only ASI (anterior supine)

- Primary total hip arthroplasty

- Revision total hip arthroplasty

Exclusion Criteria:

- • Subjects more than 85 years of age

- Subjects who will be or have undergone bilateral total hip replacements

- Subject is known to be pregnant or nursing

- Subject is an alcohol or drug abuser

- Subject has a psychiatric illness or cognitive deficit that will not allow for proper informed consent

结果

主要结果指标

1. CoMatryx Surgical Bovine Collagen [This study will require following-up with patients up to 1-year post surgery. The estimated time of completion from enrollment (100 patients) to completing 1 year follow-up is 2 years.]

The primary objective is to confirm safety and performance of the study product. This will be assessed by recording the rate of healing, incidence and frequency of complications and adverse events relative to the surgical incision at 1-week, 2-week, 6-week, 6-month and 1-year follow-up. Height and Weight will be combined as BMI(kg/m^2)

2. CoMatryx Surgical Bovine Collagen Height and Weight [This study will require following-up with patients up to 1-year post surgery. The estimated time of completion from enrollment (100 patients) to completing 1 year follow-up is 2 years.]

Height and Weight will be combined as BMI(kg/m^2)

次要成果指标

1. Bovine Collagen [This study will require following-up with patients up to 1-year post surgery. The estimated time of completion from enrollment (100 patients) to completing 1 year follow-up is 2 years.]

The secondary objective is the assessment of clinical benefits by analyzing recorded subject-reported pain scores

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge